Published on 2/6/2019 in the Prospect News Structured Products Daily.
New Issue: RBC sells $270,000 contingent coupon barrier autocallables on two pharma stocks
By Marisa Wong
Morgantown, W.Va., Feb. 6 – Royal Bank of Canada priced $270,000 of autocallable contingent coupon barrier notes due Feb. 3, 2022 linked to the least performing of the common stocks of GlaxoSmithKline plc and Pfizer Inc., according to a 424B2 filing with the Securities and Exchange Commission.
The notes will pay a quarterly coupon at an annual rate of 9.45% if all the stocks close at or above their coupon barriers, 70% of their initial prices, on the applicable quarterly observation date.
The notes will be called at par plus the coupon if each stock closes at or above its initial price on any quarterly observation date starting on July 29.
The payout at maturity will be par plus the final coupon unless any stock finishes below its 70% trigger price, in which case investors will lose 1% for each 1% that the least-performing stock’s final price is less than its initial price.
RBC Capital Markets, LLC is the agent.
Issuer: | Royal Bank of Canada
|
Issue: | Autocallable contingent coupon barrier notes
|
Underlying stocks: | GlaxoSmithKline plc (Symbol: GSK) and Pfizer Inc. (Symbol: PFE)
|
Amount: | $270,000
|
Maturity: | Feb. 3, 2022
|
Coupon: | 9.45%, payable quarterly if each stock closes at or above coupon barrier on observation date for that quarter
|
Price: | Par
|
Payout at maturity: | Par unless any stock finishes below trigger price, in which case par plus return of the least-performing stock
|
Call: | Starting July 29, automatically at par if each stock closes at or above initial price on any quarterly observation date
|
Initial prices: | 1,452.20p for GlaxoSmithKline, $40.77 for Pfizer
|
Coupon barriers: | 1,016.54p for GlaxoSmithKline, $28.54 for Pfizer; 70% of initial prices
|
Trigger prices: | 1,016.54p for GlaxoSmithKline, $28.54 for Pfizer; 70% of initial prices
|
Pricing date: | Jan. 29
|
Settlement date: | Jan. 31
|
Agent: | RBC Capital Markets, LLC
|
Fees: | 2.25%
|
Cusip: | 78013XXR4
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.